Ausgabe 6/2012
Inhalt (13 Artikel)
Merkel cell carcinoma: What do we know about it and what should we do?
Isabel Prieto Muñoz, José Pardo Masferrer, Jesús Olivera Vegas, José Ramón Fortes Alen, Ana M. Pérez Casas
Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles
Juan Bayo, Paula J. Fonseca, Susana Hernando, Sonia Servitja, Aitana Calvo, Sandra Falagan, Estefanía García, Iria González, María José de Miguel, Quionia Pérez, Ana Milena, Antonio Ruiz, Agustí Barnadas
Functions and workload of medical oncologists in Spain
Cristina Grávalos, Javier Salvador, Joan Albanell, Agustín Barnadas, Pablo Borrega, Jesús García-Mata, Pilar Garrido, Encarnación González-Flores, Dolores Isla, María Lomas, Álvaro Rodríguez-Lescure, Juan Jesús Cruz, Emilio Alba
Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study
Pedro Sánchez-Rovira, Antonio Antón, Agustí Barnadas, Amalia Velasco, María Lomas, María Rodríguez-Pinilla, José Luis Ramírez, César Ramírez, María José Ríos, Eva Castellá, Carmen García-Andrade, Belén San Antonio, Eva Carrasco, José Luis Palacios
Clinical study on the recombinant human endostatin regarding improving the blood perfusion and hypoxia of non-small-cell lung cancer
Xiao-Dong Jiang, Peng Dai, Yun Qiao, Jin Wu, Da-An Song, Shi-Qiu Li
Expanding Sca-1+ mammary stem cell in the presence of oestrogen and growth hormone
Xiaowei Dou, Bin Zhang, Rui Liu, Jing Li, Dan Shi, Chunhua Lu, Xishan Zhu, Lianming Liao, Zhijian Du, Robert Chunhua Zhao
Biological markers of cisplatin resistance in advanced testicular germ cell tumours
Adelaida García-Velasco, Ignacio Durán, Elena García, Miquel Tarón, Claudio Ballestín, Daniel Castellanos, Hernán Cortés-Funés, Luis Paz-Ares
Trends in prostate cancer survival in Spain: results from population-based cancer registries
Rafael Marcos-Gragera, Diego Salmerón, Isabel Izarzugaza, Eva Ardanaz, Bernat-Carles Serdà, Nerea Larrañaga, Erkuden San Román, Carmen Navarro, María-Dolores Chirlaque
Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC
Xiao-Dong Jiang, Yun Qiao, Peng Dai, Jin Wu, Da-An Song, Shi-Qiu Li, Yue-Wei Fan
Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience
Robert Díaz Beveridge, Jorge Aparicio, Alejandro Tormo, Rafael Estevan, Josefina Artes, Alejandra Giménez, Ángel Segura, Susana Roldán, Rosana Palasí, David Ramos
Behaviour of breast cancer molecular subtypes through tumour progression
Carlos A. Castaneda, Eva Andrés, Carmen Barcena, Henry L. Gómez, Hernán Cortés-Funés, Eva Ciruelos
Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy
Cesar Gómez-Raposo, Mónica Andreu, Inés Suárez-García, M. Isabel Esteban, Mar Carballo, María F. Sereno-Moyano, José L. Vázquez Osorio, Javier Heras, Francisco Zambrana Tévar, Eva Pelayo, Miriam López-Gómez, Clara García de Santiago, María Merino Salvador, Enrique Casado